Mylo

Mylo

Mylo has been developed as a non-medicated anti-diarrhoeal probiotic and was approved for commercialisation in New Zealand, from mid-2017. The product is designed to improve health and vitality of young animals and enhance growth and development. Sales have commenced in New Zealand and applications are being prepared to allow commercialisation in Australia and other international markets.